Department of Clinical Epidemiology, Leiden University Medical Center, 2300RC Leiden, the Netherlands.
Department of Internal Medicine, Section of Gerontology and Geriatrics, Leiden University Medical Center, 2300 RC Leiden, the Netherlands.
J Clin Endocrinol Metab. 2021 Oct 21;106(11):e4438-e4447. doi: 10.1210/clinem/dgab477.
Weight gain during adulthood increases cardiometabolic disease risk, possibly through adipocyte hypertrophy.
We aimed to study the specific metabolomic profile of adult weight gain, and to examine its association with adipocyte volume.
Nuclear magnetic resonance-based metabolomics were measured in the Netherlands Epidemiology of Obesity (NEO) study (n = 6347, discovery) and Oxford Biobank (n = 6317, replication). Adult weight gain was calculated as the absolute difference between body mass index (BMI) at middle age and recalled BMI at age 20 years. We performed linear regression analyses with both exposures BMI at age 20 years and weight gain, and separately with BMI at middle age in relation to 149 serum metabolomic measures, adjusted for age, sex, and multiple testing. Additionally, subcutaneous abdominal adipocyte biopsies were collected in a subset of the Oxford Biobank (n = 114) to estimate adipocyte volume.
Mean (SD) weight gain was 4.5 (3.7) kg/m2 in the NEO study and 3.6 (3.7) kg/m2 in the Oxford Biobank. Weight gain, and not BMI at age 20 nor middle age, was associated with concentrations of 7 metabolomic measures after successful replication, which included polyunsaturated fatty acids, small to medium low-density lipoproteins, and total intermediate-density lipoprotein. One SD weight gain was associated with 386 μm3 (95% CI, 143-629) higher median adipocyte volume. Adipocyte volume was associated with lipoprotein particles specific for adult weight gain.
Adult weight gain is associated with specific metabolomic alterations of which the higher lipoprotein concentrations were likely contributed by larger adipocyte volumes, presumably linking weight gain to cardiometabolic disease.
成年人的体重增加会增加心血管代谢疾病的风险,这可能是通过脂肪细胞肥大实现的。
我们旨在研究成年体重增加的特定代谢组学特征,并研究其与脂肪细胞体积的关系。
在荷兰肥胖症流行病学研究(NEO)(n=6347,发现)和牛津生物库(n=6317,复制)中,使用基于核磁共振的代谢组学进行了研究。成年体重增加被计算为中年时的体重指数(BMI)与 20 岁时回忆的 BMI 之间的绝对差异。我们分别使用 BMI 作为 20 岁时和体重增加的暴露因素,以及使用 BMI 作为中年的暴露因素,与 149 种血清代谢物进行了线性回归分析,这些分析均经过年龄、性别和多次检验调整。此外,在牛津生物库的一个亚组中收集了皮下腹部脂肪细胞活检(n=114),以估计脂肪细胞体积。
在 NEO 研究中,平均(SD)体重增加为 4.5(3.7)kg/m2,在牛津生物库中为 3.6(3.7)kg/m2。体重增加,而不是 20 岁时的 BMI 或中年时的 BMI,与成功复制的 7 种代谢物测量结果相关,其中包括多不饱和脂肪酸、小至中等低密度脂蛋白和总中间密度脂蛋白。1 SD 的体重增加与中位数脂肪细胞体积增加 386 μm3(95%CI,143-629)相关。脂肪细胞体积与特定于成人体重增加的脂蛋白颗粒相关。
成年体重增加与特定的代谢组学改变相关,其中较高的脂蛋白浓度可能是由较大的脂肪细胞体积引起的,这可能将体重增加与心血管代谢疾病联系起来。